Latest News
FibroBiologics, Inc.
- FibroBiologics presents data on disc disease treatment approach
- FibroBiologics receives Australian patent acceptance for disc treatment
- FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
- FibroBiologics (FBLG) Slips to $0.96 as Shares Test Key Support Zone - Wave Equality
- FibroBiologics, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (FBLG)
- FibroBiologics raises $1.2M via convertible debenture from Peak One
- FibroBiologics Secures $1.2 Million OID Debenture From Peak One With 125,000 Commitment Shares
- FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
- FibroBiologics, Inc. Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside The Body
- FibroBiologics files patent for cell-based peptide delivery By Investing.com
- FibroBiologics, Inc. announced that it has received $1.02 million in funding from Peak One Investments, LLC
- EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 Injections
Headlines from the last 30 days, linking to the original publishers. See all market news →